the year 2017, attached please find the Management Discussion and Analysis (MD&A) of the year 2017. This report should be considered in conjunction with the submitted financial statements in which the
find out that they are controlled and managed in the acceptable levels. From the following reasons concluding that the operating results of the Company of year 2017 decreased comparing to last year. For
, please kindly find the following attachment. Please kindly be informed accordingly. Yours faithfully, Mr. Geza Emil Perlaki Managing Director For period ended 31 December 2017 MANAGEMENT DISCUSSION AND
find the following attachment. Please kindly be informed accordingly. Yours faithfully, Mr. Geza Emil Perlaki Managing Director For period ended 31 March 2019 MANAGEMENT DISCUSSION AND ANALYSIS Golden
the Company and its shareholders. Due to the biopharmaceuticals products for eliminate the water hyacinth are the new innovative products that has passed the researched and testing until find that can
the Company and its subsidiary, please kindly find the following attachment. Please kindly be informed accordingly. Yours faithfully, Mr. Geza Emil Perlaki Managing Director For period ended 31 March
results of the Company and its subsidiary, please kindly find the following attachment. Please kindly be informed accordingly. Yours faithfully, Mr. Geza Emil Perlaki Managing Director For period ended 30
operating results of the Company and its subsidiary, please kindly find the following attachment. Please kindly be informed accordingly. Yours faithfully, Mr. Geza Emil Perlaki Managing Director For period
Financial Statements for the Second quarter ended June 30,2020. Please find enclosed the Management Discussion and Analysis Please be informed accordingly. Yours sincerely -Signed - Miss.Pakatip Lopandhsri